US4634689A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Phosphinylalkanoyl imino acids
Assignee: Merck Sharp & Dohme LLC
•
Filing: 1985-10-31
•
Granted: 1987-01-06
•
Expires: 2005-10-31
Abstract
Abstract Phosphinylalkanoyl imino acids useful in the treatment of hypertension are disclosed.
Inventors
- 👤 Joseph T. Witkowski
- 👤 Michael F. Czarniecki
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 12:35
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/6536; C07F9/6544; C07F9/6547
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
401 words
A compound represented by the formula ##STR26## wherein X is ##STR27## D is ##STR28## or a bond; m, n, and r are independently 0-14; x is 1-4; p and q are independently 0 or 1, provided that the sum of p and q is 1 or 2; s is 2 or 3; t is 1-3; R is hydrogen, lower alkyl, halogen-substituted lower alkyl, cycloloweralkyl, --(CH 2 ) u -cycloloweralkyl, or --(CH 2 ) v --C 6 H 5 , wherein u is 1-4 and v is 0-4; R 1 is hydroxy, alkoxy having from 1 to 8 carbon atoms, phenylloweralkoxy, allyloxy, R 9 --Q w --(CH 2 ) y --O--, wherein Q is oxygen or sulfur, w is 0 or 1 and y is 2 to 4, ##STR29## wherein the alkyl has from 3 to 8 carbon atoms, ##STR30## wherein the phenyl may be substituted with group T defined below, 1-glyceryl, ##STR31## R 2 is R or heterocycloloweralkyl, wherein heterocyclo is a 5- or 6-membered aliphatic or aromatic ring of 3 to 5 carbon atoms and 1 to 3 heteroatoms selected from nitrogen, sulfur and oxygen; R 3 is hydrogen or lower alkyl; R 4 and R 5 are independently hydrogen, lower alkyl or cycloloweralkyl, or R 4 and R 5 together with the carbon atoms to which they are attached form a 5- or 6-membered ring; R 6 and R 7 are independently hydrogen, lower alkyl or cycloloweralkyl, or R 6 and R 7 together with the nitrogen and carbon atoms to which they are attached form a 4-, 6-, 7- or 8-membered ring; R 8 is R 1 , amino, hydroxylamino, mono- or disubstituted amino wherein the substituents are lower alkyl, phenyl or phenylloweralkyl, and wherein the phenyl may be substituted with group T defined below; R 9 is phenyl, substituted phenyl wherein the substituents are chosen from group T, 1-naphthyl or 2-naphthyl; T is halogen, hydroxy, trifluoromethyl, lower alkoxy, lower alkyl, 2-furanyl, 3-furanyl, 2-thienyl, 3-thienyl, phenyl and substituted phenyl wherein the substituents are chosen from halogen, hydroxy, trifluoromethyl, lower alkoxy or lower alkyl; R 10 is hydrogen or alkyl having from 1 to 8 carbon atoms; R 11 is hydrogen, lower alkyl, unsubstituted or substituted phenyl and substituted or unsubstituted phenylloweralkyl wherein phenyl may be substituted by group T; R 12 is hydrogen or lower alkyl; R 13 is chloro or trifluoromethyl; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim
401 words
A compound represented by the formula ##STR26## wherein X is ##STR27## D is ##STR28## or a bond; m, n, and r are independently 0-14; x is 1-4; p and q are independently 0 or 1, provided that the sum of p and q is 1 or 2; s is 2 or 3; t is 1-3; R is hydrogen, lower alkyl, halogen-substituted lower alkyl, cycloloweralkyl, --(CH 2 ) u -cycloloweralkyl, or --(CH 2 ) v --C 6 H 5 , wherein u is 1-4 and v is 0-4; R 1 is hydroxy, alkoxy having from 1 to 8 carbon atoms, phenylloweralkoxy, allyloxy, R 9 --Q w --(CH 2 ) y --O--, wherein Q is oxygen or sulfur, w is 0 or 1 and y is 2 to 4, ##STR29## wherein the alkyl has from 3 to 8 carbon atoms, ##STR30## wherein the phenyl may be substituted with group T defined below, 1-glyceryl, ##STR31## R 2 is R or heterocycloloweralkyl, wherein heterocyclo is a 5- or 6-membered aliphatic or aromatic ring of 3 to 5 carbon atoms and 1 to 3 heteroatoms selected from nitrogen, sulfur and oxygen; R 3 is hydrogen or lower alkyl; R 4 and R 5 are independently hydrogen, lower alkyl or cycloloweralkyl, or R 4 and R 5 together with the carbon atoms to which they are attached form a 5- or 6-membered ring; R 6 and R 7 are independently hydrogen, lower alkyl or cycloloweralkyl, or R 6 and R 7 together with the nitrogen and carbon atoms to which they are attached form a 4-, 6-, 7- or 8-membered ring; R 8 is R 1 , amino, hydroxylamino, mono- or disubstituted amino wherein the substituents are lower alkyl, phenyl or phenylloweralkyl, and wherein the phenyl may be substituted with group T defined below; R 9 is phenyl, substituted phenyl wherein the substituents are chosen from group T, 1-naphthyl or 2-naphthyl; T is halogen, hydroxy, trifluoromethyl, lower alkoxy, lower alkyl, 2-furanyl, 3-furanyl, 2-thienyl, 3-thienyl, phenyl and substituted phenyl wherein the substituents are chosen from halogen, hydroxy, trifluoromethyl, lower alkoxy or lower alkyl; R 10 is hydrogen or alkyl having from 1 to 8 carbon atoms; R 11 is hydrogen, lower alkyl, unsubstituted or substituted phenyl and substituted or unsubstituted phenylloweralkyl wherein phenyl may be substituted by group T; R 12 is hydrogen or lower alkyl; R 13 is chloro or trifluoromethyl; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
12 words
A compound of claim 1 wherein Z is represented by formula IIIa.
Claim 4
Dependent Claim
9 words
A compound of claim 2 wherein A is ##STR32##
Claim 5
Dependent Claim
9 words
A compound of claim 3 wherein D is ##STR33##
Claim 6
Dependent Claim
10 words
A compound of claim 3 wherein D is a bond.
Claim 7
Dependent Claim
9 words
A compound of claim 2 wherein A is ##STR34##
Claim 8
Dependent Claim
12 words
A compound of claim 1 wherein Z is represented by formula IIIb.
Claim 9
Dependent Claim
9 words
A compound of claim 7 wherein B is ##STR35##
Claim 10
Dependent Claim
10 words
A compound of claim 7 wherein B is a bond.
Claim 11
Dependent Claim
9 words
A compound of claim 7 wherein B is ##STR36##
Claim 12
Dependent Claim
9 words
A compound of claim 10 wherein D is ##STR37##
Claim 13
Dependent Claim
10 words
A compound of claim 10 wherein D is a bond.
Claim 14
Dependent Claim
12 words
A compound of claim 1 wherein X is represented by formula IIa.
Claim 15
Dependent Claim
12 words
A compound of claim 1 wherein X is represented by formula IIb.
Claim 16
Dependent Claim
12 words
A compound of claim 1 wherein X is represented by formula IIc.
Claim 17
Dependent Claim
12 words
A compound of claim 1 wherein X is represented by formula IId.
Claim 18
Dependent Claim
12 words
A compound of claim 1 wherein X is represented by formula IIe.
Claim 19
Dependent Claim
10 words
A compound of claim 14 wherein each Y is --S--.
Claim 20
Dependent Claim
21 words
An antihypertensive pharmaceutical composition comprising an antihypertensive effective amount of a compound of claim 1 together with a pharmaceutically acceptable carrier.
Claim 21
Dependent Claim
26 words
A method of reducing blood pressure in hypertensive mammals which comprises administering to a hypertensive mammal a antihypertensive effective amount of a compound of claim 1.
Claim 22
Dependent Claim
22 words
A method for reducing blood pressure in an hypertensive mammals which comprises administering to a hypertensive mammal pharmaceutical composition of claim 19.
References Cited (Backward Citations)
US4384123A
Cited
US4337201A
Cited
EP0063896A1
Cited
US4338435A
Cited
US4555506A
Cited
US4431645A
Cited
US4431644A
Cited
US4560680A
Cited
US4452791A
Cited
US4427665A
Cited
US4468519A
Cited
US4444765A
Cited
US4468396A
Cited
DE3410847A1
Cited
US4555579A
Cited
US4556655A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-01-05 | 1990-07-07 | 1991-01-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-01-05 | 1994-07-07 | 1995-01-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-01-05 | 1998-07-07 | 1999-01-06 | $7700.00 | Window Closed / Lapsed |